MGD009/MGA012 Combination in Relapsed/Refractory Cancer

Clinical trial NCT03406949 · COMPLETED

Trial details

NCT number: NCT03406949
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2018-02-27
Primary completion: 2022-04-27
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.